Ting, W. (2023). A novel intergenic region (chr2: 30,193,816)-ALK fusion shows sensitivity to Alectinib in lung adenocarcinoma. Springer.
Trích dẫn theo kiểu ChicagoTing, Wang. A Novel Intergenic Region (chr2: 30,193,816)-ALK Fusion Shows Sensitivity to Alectinib in Lung Adenocarcinoma. Springer, 2023.
Trích dẫn MLATing, Wang. A Novel Intergenic Region (chr2: 30,193,816)-ALK Fusion Shows Sensitivity to Alectinib in Lung Adenocarcinoma. Springer, 2023.
Cảnh báo! Những trích dẫn này có thể không chính xác 100%.